<?xml version="1.0" encoding="UTF-8"?>
<p>Although most patients in this study presented with mild symptoms (92%), half needed oxygen therapies at least once throughout the disease course. This result was similar to other studies from Hubei province [
 <xref rid="CIT0013" ref-type="bibr">13</xref>,
 <xref rid="CIT0014" ref-type="bibr">14</xref>]. For example, a study in Wuhan found that a higher proportion of non-survivors received HFNO therapy, mechanical ventilation and ECMO with 19.5%, 5.2% and 0%, surviving after receiving these treatments, respectively [
 <xref rid="CIT0012" ref-type="bibr">12</xref>]. In our study, the corresponding proportion of all cases who received these therapies were 7%, 7% and 2%, which was indicative of the relatively strong pathogenicity of SARS-CoV-2.
</p>
